Corcept Therapeutics (CORT) Common Equity (2010 - 2026)
Corcept Therapeutics' Common Equity was $705.78 million in Q2 2026, up 11.0% from $635.79 million a year earlier and up 10.6% from the prior quarter.
Corcept Therapeutics (CORT) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Corcept Therapeutics came in at $647.81 million, down 4.7% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 4.4% (FY2020 to FY2025).
- In earlier years, Common Equity was $679.59 million in FY2024 (+34.1%), $506.71 million in FY2023 (+1.0%), $501.84 million in FY2022 (+33.5%) and $375.81 million in FY2021 (-28.2%).
- The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q4 2010.
- Compared with a year earlier, Common Equity was higher in five of the last eight quarters, with growth averaging 12.8%.
- The best year-over-year quarter for Common Equity over five years was Q2 2024 (growth of 41.4%); the worst was Q4 2021 (a decline of 28.2%).
- Per Business Quant data, CORT's Common Equity in the three quarters before Q2 2026 was $637.99 million (Q1 2026), $647.81 million (Q4 2025) and $631.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Corcept Therapeutics | 12.50 Bn | 11.06 Bn | 252.09 Mn | 705.78 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 705.78 Mn |
| Mar 31, 2026 | 637.99 Mn |
| Dec 31, 2025 | 647.81 Mn |
| Sep 30, 2025 | 631.90 Mn |
| Jun 30, 2025 | 635.79 Mn |
| Mar 31, 2025 | 683.29 Mn |
| Dec 31, 2024 | 679.59 Mn |
| Sep 30, 2024 | 638.84 Mn |
| Jun 30, 2024 | 596.24 Mn |
| Mar 31, 2024 | 547.86 Mn |
| Dec 31, 2023 | 506.71 Mn |
| Sep 30, 2023 | 461.68 Mn |
| Jun 30, 2023 | 421.61 Mn |
| Mar 31, 2023 | 529.58 Mn |
| Dec 31, 2022 | 501.84 Mn |
| Sep 30, 2022 | 473.36 Mn |
| Jun 30, 2022 | 442.33 Mn |
| Mar 31, 2022 | 407.81 Mn |
| Dec 31, 2021 | 375.81 Mn |
| Sep 30, 2021 | 540.23 Mn |
Corcept Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CORT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();